11/03/2024Published by Fondazione Gianni Bonadonna at 11/03/2024Categories Events UncategorizedctDNA analysis in gastrointestinal stromal tumors treated with ripretinib or sunitinib
04/03/2024Published by Fondazione Gianni Bonadonna at 04/03/2024Categories Events UncategorizedAdditivity predicts efficacy of therapies for advanced cancer
26/02/2024Published by Fondazione Gianni Bonadonna at 26/02/2024Categories Events UncategorizedImproved outcome with pembrolizumab added to chemotherapy in mesothelioma
19/02/2024Published by Fondazione Gianni Bonadonna at 19/02/2024Categories Events UncategorizedPerioperative durvalumab in non-small-cell lung cancer
12/02/2024Published by Fondazione Gianni Bonadonna at 12/02/2024Categories Events UncategorizedTwo young researchers awarded with two fellowships at the third edition of the Call in memory of Gianni Bonadonna
05/02/2024Published by Fondazione Gianni Bonadonna at 05/02/2024Categories Events UncategorizedAtezolizumab and bevacizumab in resected or ablated high-risk hepatocellular carcinoma
29/01/2024Published by Fondazione Gianni Bonadonna at 29/01/2024Categories Events UncategorizedPemigatinib in metastatic or surgically unresectable urothelial carcinoma
22/01/2024Published by Fondazione Gianni Bonadonna at 22/01/2024Categories Events UncategorizedDostarlimab monotherapy in mismatch repair deficient solid tumors
15/01/2024Published by Fondazione Gianni Bonadonna at 15/01/2024Categories Events UncategorizedRibociclib plus hormone therapy improves outcomes in early stage HR+/HER2- breast cancer
